atazanavir
J - Antiinfectives For Systemic Use -> J05 - Antivirals For Systemic Use -> J05A - Direct Acting Antivirals -> J05AE - Protease Inhibitors -> J05AE08 - Atazanavir
Administration category:
Free
Medicine group:
antiviral
Brand name:
Reyataz
Standard dosages
| Weight | ROA | Load | Dosage | |
|---|---|---|---|---|
|
ROA: po |
Load: - |
Dosage: 300mg 1 dd |
||
|
ROA: po |
Load: - |
Dosage: 400mg 1 dd |
||
|
Comments:
In combinatie met ritonavir: 300 mg atazanavir + 100 mg ritonavir 1 dd po. Indien tevens nevirapine/efavirenz: 400 mg atazanavir + 100 mg ritonavir 1 dd po |
||||
Kidney function
Renal elimination:
7%
Dosage:
independent on kidney function
Renal function-replacement therapy
Hemo dialysis: not dialized
Pregnancy
Due to the expiration of the alphanumeric classification for use in pregnancy and lactation, reference is made to the current, online information of the Teratology Information Service (TIS) of LAREB:
- http://www.lareb.nl//Teratologie/Naslagwerk-GZB/GZB---Zwangerschap#TOC_Middelen_bij6
- http://www.lareb.nl//Teratologie/Naslagwerk-GZB/GZB---Borstvoeding#TOC_Middelen_bij16
For individual advice, consult an expert on site.
Metadata
Swab vid: M-1864.1
Updated: 06/16/2019 - 20:05
Status: Published